Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
For many, Alzheimer's disease is the number one medical issue facing our aging society. It is
a late onset neurodegenerative disease, frequently under diagnosed, that impairs memory and
cognitive performance. There are no known treatments that can either prevent or reverse its
progression. Consequently, there still remains a need to evaluate treatments which can better
stabilize the symptoms of this disease. These symptoms frequently include decreased
functional capacity and negative psychological attributes (e,g, depression, anxiety) in
association with the memory and cognition deficits. This current study is being done to
assess an investigational compound that has been designed to not only improved the cognitive
status of affected patients but to also better manage all symptoms. Hence, the ultimate goal
is to provide patients with an improved quality of life by slowing the progression of this
neurodegenerative disease